Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
9351
CALL
Cullinan Oncology
CGEM
$1.31B
| $351K | ﹤0.01% |
27,400
-101,900
| -79% | -$1.16M |
|
9352
GATX Corp
GATX
$6.38B
| $351K | ﹤0.01% |
+3,734
| New | +$398K |
|
9353
Invitation Homes
INVH
$18B
| $351K | ﹤0.01% |
9,876
-540,526
| -98% | -$20.6M |
|
9354
NewMarket
NEU
$8.85B
| $351K | ﹤0.01% |
1,165
-7,929
| -87% | -$2.56M |
|
|
OPI
9355
CALL
DELISTED
Office Properties Income Trust
OPI
| $351K | ﹤0.01% |
17,600
+3,000
| +21% | +$64.9K |
|
9356
Pacer Swan SOS Moderate October ETF
PSMO
$101M
| $351K | ﹤0.01% |
+17,898
| New | +$362K |
|
9357
PUT
ACI Worldwide
ACIW
$5.4B
| $350K | ﹤0.01% |
13,500
-18,400
| -58% | -$495K |
|
9358
PUT
ACM Research
ACMR
$5.6B
| $350K | ﹤0.01% |
20,800
-138,200
| -87% | -$2.13M |
|
9359
CALL
Fortis
FTS
$29B
| $350K | ﹤0.01% |
7,400
+3,100
| +72% | +$152K |
|
|
FUNL
9360
DELISTED
CornerCap Fundametrics Large-Cap ETF
FUNL
| $350K | ﹤0.01% |
+11,295
| New | +$377K |
|
9361
Preformed Line Products
PLPC
$2.27B
| $350K | ﹤0.01% |
+5,691
| New | +$352K |
|
9362
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $350K | ﹤0.01% |
11,820
-12,940
| -52% | -$416K |
|
9363
Pacer Swan SOS Flex October ETF
PSFO
$39M
| $350K | ﹤0.01% |
+17,856
| New | +$362K |
|
9364
CALL
Supernus Pharmaceuticals
SUPN
$2.81B
| $350K | ﹤0.01% |
12,100
-2,500
| -17% | -$71.6K |
|
9365
CALL
Cactus
WHD
$5.88B
| $350K | ﹤0.01% |
8,700
+1,200
| +16% | +$60.3K |
|
|
EIGR
9366
CALL
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $350K | ﹤0.01% |
1,853
-214
| -10% | -$43.1K |
|
9367
CALL
Smartbird Inc
BIRD
$30.1M
| $349K | ﹤0.01% |
4,440
-11,060
| -71% | -$1.12M |
|
9368
CALL
Carpenter Technology
CRS
$27B
| $349K | ﹤0.01% |
12,500
-26,000
| -68% | -$925K |
|
9369
Glaukos
GKOS
$10.9B
| $349K | ﹤0.01% |
7,684
-47,361
| -86% | -$2.25M |
|
9370
CALL
Home BancShares
HOMB
$6.28B
| $349K | ﹤0.01% |
16,800
+5,100
| +44% | +$110K |
|
9371
Pacer Data & Infrastructure Real Estate ETF
SRVR
$391M
| $349K | ﹤0.01% |
10,121
-40,441
| -80% | -$1.48M |
|
9372
CALL
Xeris Biopharma Holdings
XERS
$1.57B
| $349K | ﹤0.01% |
226,300
+21,000
| +10% | +$44.3K |
|
|
VIA
9373
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $349K | ﹤0.01% |
+9,105
| New | +$358K |
|
|
WE
9374
PUT
DELISTED
WeWork Inc.
WE
| $349K | ﹤0.01% |
1,740
-2,568
| -60% | -$661K |
|
|
IS
9375
CALL
DELISTED
ironSource Ltd.
IS
| $349K | ﹤0.01% |
146,800
+22,300
| +18% | +$74.7K |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.